XVII ICPLM

Dr. Kohse studied Chemistry and Medicine (1970-1980) at the universities of Bochum, Essen, Ulm
and Tübingen (Germany). He was resident in Internal Medicine (Nephrology) at the University
Hospital of Ulm, followed by a residency in Clinical Pathology (Laboratory Medicine) at the Robert-
Bosch-Hospital Stuttgart (Germany), academic hospital for the University of Tübingen. As
Postdoctoral Fellow (1987/88), he worked at the Department of Pharmacology and Medicine,
Stanford University Medical School, in the lab of Prof. Ferid Murad. Past research concerned projects
on muscle biochemistry, development of immunoassays, carnitine metabolism in renal disease,
adrenergic receptors, cardiac natriuretic peptides, and quality management in the clinical laboratory.
Dr. Kohse is former Director of the Institute for Laboratory Diagnostics and Microbiology, Klinikum
Oldenburg (Germany), and Professor for Clinical Chemistry and Pathobiochemistry at the Faculty of
Medicine and Health Sciences, Carl von Ossietzky University Oldenburg, where he also served as
Dean of Education.

Dr. Lianna Kyriakopoulou is a Clinical Molecular Geneticist and Clinical Biochemist. She is an Associate Professor at the University of Toronto, Project Investigator at the Research Institute at the Hospital for Sick Children and a member of the Translational Genomics Program.

Her research interests are focusing on the development of functional genomic platforms and translation of high complexity omics-testing in the clinical laboratory. Her more recent research has focused on developing clinical transcriptomics in the clinical space as a new tool for precision diagnostics, currently used for the diagnosis of rare diseases and cancers and is carving a path for Precision Child Health initiatives within the Hospital for Sick Children.  Her work is focusing on mapping and identifying the molecular effects of rare genetic variants and is linked to multiple major genomics projects.

Dr. Kyriakopoulou is a member of the International Organization for Standardization (ISO) and the Canadian Standards Association. She is currently the chair of the Committee for Emerging Technologies in Pediatric Lab Medicine of the IFCC. She has also served as the Chair of the board of the Canadian Academy of Clinical Biochemistry and in several other positions within the board of the CACB and the Canadian Society of Clinical Chemists.